On Wednesday, April 11th, SAFC announced the launch of the CHOZN cell platform system for biopharma producers to create and scale up high producing clones more quickly and easily. Here, SAFC Live speaks to Kevin Kayser, Associate Director of Cell Sciences and Development at SAFC, about why the platform was developed, and what it can do.
Archive for the ‘ZFN’ Category
A Deeper Look Into the New CHOZN® Platform System for Recombinant Protein Production
Friday, April 13th, 2012BREAKING NEWS: SAFC Launches CHOZN® Platform System to Accelerate Recombinant Protein Drug Development
Wednesday, April 11th, 2012Today, SAFC announced the launch of the CHOZN® Platform System to accelerate recombinant protein drug development. The new platform allows faster and simpler selection of high producing clones for use in recombinant protein drugs, as well as facilitating a more efficient scale-up process. The full press release is available below.
Nature Method Award Celebrates SAFC’s ZFN Technology
Monday, April 9th, 2012For the third year in a row, SAFC is the proud winner of a Nature Method award. The awards, presented annually by Nature.com, highlight revolutionary methods in genome and cell products and manufacturing. In 2012, SAFC received the award for their ZFN technology. An abstract highlighting the winning presentation follows: http://www.nature.com/nmeth/journal/v9/n1/full/nmeth.1805.html.
To learn more about SAFC’s Cell Design Studio, which includes ZFN technologies and services, please click here.
To directly contact SAFC for more information about products and services, please click here.
SAFC at Informex 2012: The Roundup
Wednesday, March 14th, 2012
-
- SAFC sponsors the Informex Networking Lounge
-
- The SAFC Booth at Informex 2012
-
- SAFC partners with Rx-360 and Informex to support Habitat for Humanity in NOLA
It is hard to believe that Informex 2012 is already a month behind us. SAFC spent a productive week at the Morial Convention Center in New Orleans, LA with industry colleagues old and new. SAFC was not only an exhibitor and presenter at the show, but also took involvement one step further through a social media sponsorship that included sponsoring the Informex Networking Lounge. Over the three days in NOLA, the Lounge offered attendees with a place to meet, network and participate in social media.
LIVE from CPhI Worldwide: SAFC Announces Introduction of CHOZN GS Knockout CHO Line
Thursday, October 27th, 2011Following the introduction of the CHO cell line earlier this year in July, SAFC has just announced the release of a novel CHOZN® GS-/- Zinc Finger Nuclease (ZFN)- modified Chinese Hamster Ovary (CHO) cell line. Designed for use in the production of biopharmaceuticals, the new CHOZN GS-/- cell line is the first commercially available glutamine synthetase (GS) knockout CHO cell line proven to shorten bioproduction times in early development, enabling customers to enhance their speed-to-market and increase cost efficiency. Read more about it on Manufacturing Chemist by clicking here.
Pharma Magazine Feature: From DNA to Harvest: A Platform Approach to Improved Bio-Production
Wednesday, September 28th, 2011The September/October issue of Pharma Magazine features an article authored by Bruce Lehr, SAFC Director of Development and Kevin Kayser, SAFC Associate Director of Cell Engineering which discusses using a platform development and manufacturing strategy to control operations across biopharmaceutical projects. The article further discusses SAFC’s ZFN (Zinc Finger Nuclease) technology which allows for the isolation of genes for modification. Please take a moment to read the full story here.
The Launch of the CHOZN Cell Line: Where it Came from and Where it is Going
Thursday, July 7th, 2011
Kevin Kayser, SAFC Associate Director Cell Sciences and Development
As the launch of the first CHOZN® cell line is announced, we talk to SAFC’s Associate Director Cell Sciences and Development, Kevin Kayser, about the cells, what they can do, and what’s to come in the future.
